831 related articles for article (PubMed ID: 31833541)
21. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users.
Wagener TL; Floyd EL; Stepanov I; Driskill LM; Frank SG; Meier E; Leavens EL; Tackett AP; Molina N; Queimado L
Tob Control; 2017 Mar; 26(e1):e23-e28. PubMed ID: 27729564
[TBL] [Abstract][Full Text] [Related]
22. Respiratory Exposure to Thirdhand Cigarette Smoke Increases Concentrations of Urinary Metabolites of Nicotine.
Pratt K; Hilty A; Jacob P; Schick SF
Nicotine Tob Res; 2023 Jul; 25(8):1424-1430. PubMed ID: 36617255
[TBL] [Abstract][Full Text] [Related]
23. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
[TBL] [Abstract][Full Text] [Related]
24. Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu
Morris P; McDermott S; Chapman F; Verron T; Cahours X; Stevenson M; Thompson J; Chaudhary N; O'Connell G
Intern Emerg Med; 2022 Mar; 17(2):397-410. PubMed ID: 34435305
[TBL] [Abstract][Full Text] [Related]
25. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.
Ashley DL; O'Connor RJ; Bernert JT; Watson CH; Polzin GM; Jain RB; Hammond D; Hatsukami DK; Giovino GA; Cummings KM; McNeill A; Shahab L; King B; Fong GT; Zhang L; Xia Y; Yan X; McCraw JM
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1389-98. PubMed ID: 20501750
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
[TBL] [Abstract][Full Text] [Related]
27. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
28. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes.
D'Ruiz CD; Graff DW; Robinson E
BMC Public Health; 2016 Jul; 16():543. PubMed ID: 27401980
[TBL] [Abstract][Full Text] [Related]
29. Carcinogen Exposure among Canadian Tobacco Users: Changes in NNK Exposure from 2007-2009 through 2012-2013.
Czoli CD; Hammond D
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):262-267. PubMed ID: 29358222
[No Abstract] [Full Text] [Related]
30. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers.
Hecht SS; Carmella SG; Kotandeniya D; Pillsbury ME; Chen M; Ransom BW; Vogel RI; Thompson E; Murphy SE; Hatsukami DK
Nicotine Tob Res; 2015 Jun; 17(6):704-9. PubMed ID: 25335945
[TBL] [Abstract][Full Text] [Related]
31. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
Xia B; Blount BC; Guillot T; Brosius C; Li Y; Van Bemmel DM; Kimmel HL; Chang CM; Borek N; Edwards KC; Lawrence C; Hyland A; Goniewicz ML; Pine BN; Xia Y; Bernert JT; De Castro BR; Lee J; Brown JL; Arnstein S; Choi D; Wade EL; Hatsukami D; Ervies G; Cobos A; Nicodemus K; Freeman D; Hecht SS; Conway K; Wang L
Nicotine Tob Res; 2021 Feb; 23(3):573-583. PubMed ID: 32716026
[TBL] [Abstract][Full Text] [Related]
32. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
[TBL] [Abstract][Full Text] [Related]
33. Effects of Menthol Flavor Cigarettes or Total Urinary Menthol on Biomarkers of Nicotine and Carcinogenic Exposure and Behavioral Measures.
Ahijevych K; Szalacha LA; Tan A
Nicotine Tob Res; 2019 Aug; 21(9):1189-1197. PubMed ID: 30137555
[TBL] [Abstract][Full Text] [Related]
34. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
[TBL] [Abstract][Full Text] [Related]
35. How Does Smoking and Nicotine Dependence Change After Onset of Vaping? A Retrospective Analysis of Dual Users.
Martínez Ú; Martínez-Loredo V; Simmons VN; Meltzer LR; Drobes DJ; Brandon KO; Palmer AM; Eissenberg T; Bullen CR; Harrell PT; Brandon TH
Nicotine Tob Res; 2020 Apr; 22(5):764-770. PubMed ID: 30883640
[TBL] [Abstract][Full Text] [Related]
36. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
[TBL] [Abstract][Full Text] [Related]
37. The relationship between nicotine metabolism and nicotine and carcinogen exposure among American Indian commercial cigarette smokers and electronic nicotine delivery system users.
Carroll DM; Wagener TL; Stephens LD; Brame LS; Thompson DM; Beebe LA
Addict Behav; 2019 May; 92():58-63. PubMed ID: 30583092
[TBL] [Abstract][Full Text] [Related]
38. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
[TBL] [Abstract][Full Text] [Related]
39. Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
Cobb CO; Foulds J; Yen MS; Veldheer S; Lopez AA; Yingst JM; Bullen C; Kang L; Eissenberg T;
Lancet Respir Med; 2021 Aug; 9(8):840-850. PubMed ID: 33857436
[TBL] [Abstract][Full Text] [Related]
40. Cigarettes with different nicotine levels affect sensory perception and levels of biomarkers of exposure in adult smokers.
McKinney DL; Frost-Pineda K; Oldham MJ; Fisher MT; Wang J; Gogova M; Kobal G
Nicotine Tob Res; 2014 Jul; 16(7):948-60. PubMed ID: 24638852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
